FIELD: medicine.
SUBSTANCE: assess the functional state of the muscles closing apparatus of the rectum. Carried out is parallel registration of bioelectrical activity in signal amplitude and pressure values alone, while volitional contraction of the sphincter, coughing, muscle tension anterior abdominal wall. It defines an interval of time T, during which the patient holds the pressure of more than 50 % of the maximum pressure registered by a volitional in contraction of the sphincter. Identify internal sphincter tone decrease at normal or reduced contractility of the external sphincter; Save or disorders of the nervous reflex connections of the external sphincter; identify signs of dyssynergia of pelvic floor muscles.
EFFECT: method allows a comprehensive assessment of the functional state of the elements RCA.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR NEUROPHYSIOLOGICAL EXAMINATION OF PELVIC FLOOR MUSCLES AND A RECTUM OBTURATIVE APPARATUS | 2020 |
|
RU2741725C1 |
| METHOD FOR TREATING OBSTRUCTIVE DEFECATION SYNDROME USING A BIOFEEDBACK METHOD | 2021 |
|
RU2771420C1 |
| METHOD FOR CORRECTING FUNCTIONAL DISORDERS OF ANAL SPHINCTER AND PELVIC FLOOR MUSCLES IN PATIENTS WITH PELVIC ORGAN PROLAPSE IN COMBINATION WITH OBSTRUCTIVE DEFECATION AND PRESENCE OR ABSENCE OF ANAL INCONTINENCE | 2021 |
|
RU2752370C1 |
| METHOD FOR CORRECTION OF DISORDERS OF FUNCTIONAL STATE OF MUSCLES OF ANAL SPHINCTER AND PELVIC FLOOR IN PATIENTS WITH ANAL INCONTINENCE | 2021 |
|
RU2753580C1 |
| METHOD OF TREATING ANAL SPHINCTER INSUFFICIENCY OF 1 AND 2 DEGREES | 2022 |
|
RU2824422C2 |
| METHOD FOR DETERMINING NEUROPHYSIOLOGICAL CONDITION OF PELVIC FLOOR MUSCLES | 2019 |
|
RU2708052C1 |
| METHOD FOR DETERMINING RELAXATION OF PELVIC DIAPHRAGM | 1991 |
|
RU2006035C1 |
| METHOD OF TREATING FUNCTIONAL CONSTIPATION | 2023 |
|
RU2809305C1 |
| METHOD FOR SURGICAL TREATMENT OF RECTAL PROLAPSE IN ELDERLY AND SENILE PATIENTS | 2000 |
|
RU2187250C1 |
| METHOD FOR PREDICTING FUNCTIONAL DISORDERS OF THE RECTAL CLOSURE APPARATUS IN PATIENTS TREATED FOR RECTAL CANCER | 2017 |
|
RU2674097C1 |
